By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD


Company News
Nine Bay Area Biotechs Vie to be the “Next Genentech (RHHBY)” 5/24/2016 6:33:42 AM
Gilead (GILD) To Present At The UBS Global Healthcare Conference On Monday, May 23 5/23/2016 9:29:27 AM
Nimbus Therapeutics Announces Closing Of Gilead (GILD)’ Acquisition Of Nimbus Apollo, Inc., And Its Acetyl-CoA Carboxylase (ACC) Inhibitor Program 5/17/2016 11:09:22 AM
Gilead (GILD) Elated as India Upholds Sovaldi Patent 5/11/2016 6:52:16 AM
Gilead (GILD) To Present At The Bank of America (BAC) Merrill Lynch Healthcare Conference On Tuesday, May 10 5/10/2016 12:14:10 PM
Gilead (GILD) CEO Targets Cancer Acquisitions with $21 Billion Cash Pile 5/9/2016 6:24:40 AM
Look Who’s Profiting from Gilead (GILD)'s Sky-High Hepatitis C Drug Prices 5/5/2016 7:17:37 AM
3 Bargain Biotechs to Buy 5/4/2016 6:40:01 AM
European CHMP Adopts Positive Opinion For Gilead (GILD)’s TAF-Based Single Tablet Regimen Odefsey (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) For Treatment Of HIV 4/29/2016 10:58:55 AM
Gilead (GILD) Announces First Quarter 2016 Financial Results 4/29/2016 10:19:33 AM